The U.S. Food and Drug Administration (FDA) has rejected an application from Verily Life Sciences that sought to add a Parkinson’s disease symptom assessment tool to the company’s clinical research-focused smartwatch. In its response letter,
Parkinsons Articles
My Top Tips for a Newly Diagnosed Parkinson’s Patient
Dear new Parkinson’s patient (aka Parkie), Welcome to your new lifelong community. It’s sort of like you are marrying the disease. “Do you, new Parkinson’s patient, take this disease to be your (maybe not one
Plant Compound May Lessen Cognitive Impairment, Mouse Study Suggests
Oral doses of silibinin — a plant compound sold as a dietary supplement — were found to lessen cognitive impairment in a mouse model of Parkinson’s disease. It worked, according to researchers, by preventing neurodegeneration
Phase 1 Trials of Bayer’s Cell and Gene Therapies Enrolling Patients
A first patient has been dosed in a still-recruiting Phase 1 clinical trial testing DA01, an investigational cell therapy for Parkinson’s disease. A separate Phase 1 trial of a potential gene therapy for Parkinson’s is
I Worry About My Parents’ Health as I Watch Them Both Age
When I stumble through the door on my recent visit home, I’m not entirely prepared for the sight that greets me. My dad looks like he’s walking through molasses, and my mom is hobbling around
Embracing Vulnerability in Parkinson’s
If you ask others what vulnerability means, they’ll often respond with something that implies weakness. Many people affected by Parkinson’s disease (PD) may believe the falsehood that they no longer are enough of a
Antipsychotic Use by Newly Diagnosed Patients Drops After FDA Warnings
The use of antipsychotics by people with early Parkinson’s disease (PD) has fallen substantially since the U.S. Food and Drug Administration (FDA) issued warnings about treating dementia with these medications, according to a database study
Senses Related to Smell May Be Predictor of Parkinson’s
A chemical sense related to smell, called the trigeminal system, may help researchers understand which people who lose their sense of smell will later develop Parkinson’s disease. Parkinson Canada is supporting this research through a
How Osteoporosis Led Me to a Hyperparathyroidism Diagnosis
A few months ago, I was flabbergasted to be diagnosed with osteoporosis. In May 2020, I shattered the ulna in my left arm when I fell off my bike. While I suspected osteoporosis might have
FDA Approves Advanced DBS System Allowing More Personalized Care
The U.S. Food and Drug Administration (FDA) has approved Medtronic‘s SenSight Directional Lead System, which offers both sensing and directional capabilities allowing for more precise use of deep brain stimulation (DBS), a widely approved surgical treatment for
Data Support Long-term Efficacy of Nuplazid for Psychosis
Treatment with Nuplazid (pimavanserin) can ease symptoms of Parkinson’s disease psychosis (PDP) for up to 10 weeks, and is generally safe and well-tolerated, according to new clinical trial data. The findings were published in Parkinsonism and
Blood Test May Distinguish Parkinson’s From Multiple System Atrophy
A highly sensitive and specific blood test has been developed that can distinguish Parkinson’s disease from multiple system atrophy (MSA), a team at the University of California, Los Angeles (UCLA) Health reported. The test examines